Skip to main content

Table 3 Sensitivity analysis including cases occurring until 2005 which were strictly validated via mailing

From: Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women

  All VTE Pulmonary embolism DVT Primary Secondary
  Cases adjusted HR* Cases adjusted HR* Cases adjusted HR* Cases adjusted HR* Cases adjusted HR*
physical act T1 413 ref 97 ref 316 ref 154 ref 259 ref
physical activity T2 422 1.04 (0.90: 1.19) 97 1.05 (0.79: 1.39) 325 1.03 (0.88: 1.21) 148 0.97 (0.77: 1.22) 274 1.08 (0.91: 1.28)
physical activity T3 394 0.98 (0.85: 1.12) 96 1.00 (0.75: 1.33) 298 0.97 (0.83: 1.14) 107 0.70 (0.54: 0.90) 287 1.14 (0.96: 1.34)
Never smoker 721 Ref 172 ref 549 ref 241 ref 480 ref
X smoker 383 0.92 (0.82: 1.05) 88 0.93 (0.72: 1.20) 295 0.92 (0.80; 1.07) 120 0.87 (0.71: 1.09) 263 0.95 (0.82: 1.10)
smoker 125 0.89 (0.74: 1.08) 30 0.99 (0.67: 1.47) 95 0.86 (0.69: 1.07) 48 1.05 (0.77: 1.44) 77 0.81 (0.64: 1.04)
hypertension 583 1.02 (0.91: 1.15) 162 1.22 (0.95: 1.56) 421 0.97 (0.84: 1.11) 191 0.96 (0.78: 1.18) 392 1.05 (0.91: 1.22)
dyslipidaemia 189 0.86 (0.73: 1.01) 52 0.87 (0.64: 1.19) 137 0.86 (0.71: 1.04) 58 0.74 (0.56: 0.99) 131 0.93 (0.76: 1.13)
diabetes 21 0.71 (0.46: 1.11) 6 0.68 (0.30: 1.54) 15 0.73 (0.44: 1.22) 10 1.01 (0.54: 1.92) 11 0.56 (0.31: 1.03)
  1. *adjusted on education level, statin use, menopause, MHT use, parity, type of menopause, family history of CVD and BMI